Trial intelligence / Profile preview

Dienogest vs Gynera for Adenomyosis

NCT03890042Completed

Sponsor
Assiut University
Start
Mar 2019
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of dienogest in adenomyosis (2 arms), sponsored by Assiut University. Primary endpoint: Number of women with improved pelvic pain at 6 months. Started Mar 2019; status: completed.

02

Drugs

dienogest
03

Conditions

adenomyosis

Beyond the preview

Go deeper on NCT03890042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03890042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call